CLINICAL EVENTS CALENDAR
- Friday, September 19, 2008 - 14:53Order and Disorder in the Cardiac Rhythm-The Basicshttp://www.orderanddisorder.com
- Friday, September 19, 2008 - 14:57IBHRExAM Prep Course - PACINGhttp://www.tcainstitute.com
- Monday, September 22, 2008 - 14:58The 9th International Dead Sea Symposium (IDSS) on Cardiac Arrhythmias and Device Therapyhttp://www.congress.co.il/arrhythmia08/home.html
- Thursday, October 2, 2008 - 15:00The California Heart Rhythm Symposiumhttp://cme.ucsd.edu
Short QT Syndrome: A New Genetic Cause of Sudden Death
Just when you thought you had heard of every possible arrhythmic syndrome, yet another new ion channelopathy is on the horizon! It is called short QT syndrome (SQTS), a hot new entity, and everybody who is anybody in electrophysiology knows something about it.
We discussed long QT syndrome (LQTS) in the January issue of EP Lab Digest.1-6 Briefly, most patients (90%) with LQTS harbor a genetic mutation in their DNA which renders the cardiac potassium channel (IKs or IKr; slow versus rapid) non-functional. The potassium channel should open and close, but these mutations cause a loss of function to the channel, or the potassium channel is always closed.
Patients with LQTS usually show a prolonged QTc interval on ECG (QTc > 450 ms) and may experience sudden death, aborted cardiac arrest, or syncope.1-6 Although it is an autosomal dominant disorder, most symptomatic patients are females. The disorder is treated with defibrillator (ICD) implantation or beta-blocker therapy, depending on the severity of the symptoms.
Short QT syndrome is basically the opposite of long QT syndrome. SQTS was mentioned briefly by Dr. Gussak and colleagues in 2000.7 It has been described in greater detail in a total of three white (European descent) families by one research group.8 These families present with a long family history of unexplained sudden death or cardiac arrest, paroxysmal atrial fibrillation, and very short QTc interval (QTc < 300 ms). It appears to be an autosomal dominant disorder which affects both men and women clinically.
These authors discuss the clinical characteristics of these families in their work. In one family, they experienced a SIDS (sudden infant death syndrome) death in a three-month-old child, and an aborted cardiac arrest in the eight-month-old sibling. Another family had a male with an unexplained cardiac arrest at age 51. The family members were screened and found to have extremely short QTc intervals. Several affected family members underwent electrophysiology (EP) studies and had easily inducible ventricular arrhythmias.
Dr. Brugada and colleagues went an extra step and attempted to define the molecular defect which causes the short QT syndrome.9 Because the affected families were too small, the authors performed a focused search for the SQTS mutations among the known LQTS genes. In an elegant piece of work, they found missense mutations in the S5-P loop region of the cardiac IKr channel HERG in two of the three SQTS families.
They performed patch-clamp analysis on these mutations to see how they affected the function of the potassium ion channel. Briefly, patch-clamp analysis is a laborious molecular lab technique to study an ion channel s function (ability to transmit ion current). The authors generated each family s SQTS mutation they had found, placed the mutations into larger gene vectors, and put those vectors into HEK cells (human embryonic kidney cells). They measured the amount of potassium current across the cells in normal HEK cells and in those with the SQTS mutations.
Interestingly, the two SQTS mutations that have been identified cause a gain of function in the IKr (HERG channel) potassium channel, or the HERG potassium channel is always open. It is the exact opposite of what LQTS does!
What these mutations do is affect the ability of the cardiac myocyte to repolarize. The mutations increase the repolarizing currents that are working during the early phase of the action potential, which shortens ventricular repolarization and thus shortens the QT interval. Given that this shortening of repolarization is heterogeneous, that would set up the substrate for reentrant arrhythmias like atrial fibrillation or ventricular fibrillation (and sudden death). Indeed, the authors have found that these SQTS patients have shorter atrial and ventricular effective refractory periods than controls, which explains why these arrhythmias can occur.10
In the literature, Dr. Schimpf et al. implanted defibrillators in the affected individuals.11
It s unclear how common short QT syndrome is. We presumably miss many cases of it since we are trained to simply look for a long QT interval on ECG (when we bother to look at the QT interval at all). It likely is rare, but it may be a cause of SIDS or another genetic cause of sudden death.
1. Wehrens XH, Vos MA, Doevendans PA, et al. Novel insights in the congenital long QT syndrome. Ann Intern Med 2002;137:981–992.
2. Vincent GM. The molecular genetics of the long QT syndrome: Genes causing fainting and sudden death. Ann Rev Med 1998;49:263–274.
3. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: Gene-specific triggers for life-threatening arrhythmias. Circulation 2001;103:89–95.
4. Zareba W, Moss AJ, Schwartz PJ, et al. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med 1998;339:960–965.
5. Locati EH, Zareba W, Moss AJ, et al. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome. Circulation 1998;97:2237–2244.
6. Moss AJ, Robinson JL, Gessman L, et al. Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol 1999;84:876–879.
7. Gussak I, Brugada P, Brugada J, et al. Idiopathic short QT interval: A new clinical syndrome? Cardiology 2000;94:99–102.
8. Gaita F, Giustetto C, Bianchi F, et al. Short QT syndrome. A familial cause of sudden death. Circulation 2003;108:965–970.
9. Brugada R, Hong K, Dumaine R, et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 2004;109:30–35.
10. Gaita F, Giustetto C, Bianchi F, et al. The short QT syndrome: A novel mechanism for both atrial and ventricular fibrillation? Abstract, November 2003, American Heart Association meeting.
11. Schimpf R, Wolpert C, Bianchi F, et al. Congenital short QT syndrome and implantable cardioverter defibrillator treatment. J Cardiovasc Electrophysiol 2003;14:1273–1277.
- Login or register to post comments
- Email this page
All Subscriptions are FREE to qualified cardiology professionals

- Subscribe to:
- Journal
- Digital Journal
- E-News
- RSS feed
Chesterfield, Missouri
Charlottesville, Virginia
Durham , North Carolina
CME Showcase
![]() New Standards of Care for CRMD Antibiotic Protection Complimentary CME Accredited Webcast Dates: November 18, 2008 Time: 6:00 pm ET November 19, 2008 Time: 3:00 pm ET This activity is sponsored by the North American Center for Continuing Medical Education. |
![]() LUMEN 2009 - THE SYMPOSIUM ON OPTIMAL TREATMENTS FOR ACUTE MI Live Symposium Date: February 26-28 Location: Loews Miami Beach Hotel Miami Beach, Florida 33139 |
![]() Challenges from Atrial Fibrillation in Heart Failure Complimentary Accredited Web Archive Target Audience: Physicians, nurses and technologists ![]() How to Manage Heart Failure Patients with CRT Devices Complimentary Accredited Web Archive Target Audience: Physicians, nurses and technologists These activities are supported by an educational grant from Biotronik. |










